November 21, 2022
PAR-21-026 - Graduate Research Training Initiative for Student Enhancement (G-RISE) (T32 - Clinical Trial Not Allowed)
National Institute of General Medical Sciences (NIGMS)
The purpose of this Notice is to alert potential applicants of a clarification in the "Eligible Organizations" section of PAR-21-026, "Graduate Research Training Initiative for Student Enhancement (G-RISE) (T32 - Clinical Trial Not Allowed)" regarding the eligibility of institutions with multiple campuses.
Part 2. Section III.1. Eligible Applicants
Currently Reads:
Eligible Organizations
Higher Education Institutions
The following types of Higher Education Institutions are always encouraged to apply for NIH support as Public or Private Institutions of Higher Education:
Nonprofits Other Than Institutions of Higher Education
Governments
Other
For diversity enhancing programs, NIGMS recognizes separate institutional eligibility tracks: research-intensive, i.e., those with an average of NIH research project grant (RPG) funding greater than or equal to $7.5 million total costs per year over the past 3 fiscal years, and research-active, i.e., those with an average of RPG funding less than $7.5 million total costs per year over the past 3 fiscal years (RPG data are available through NIH RePORTER). For example, FY 2018, FY 2019 and FY 2020 for applications submitted in January 2021.
Institutional eligibility for this FOA is limited to research-active institutions as defined above. Research-intensive institutions are not eligible to apply for or receive G-RISE grants. To prevent the duplication of NIGMS diversity enhancing programs, each institution is eligible for one undergraduate program (either MARC or U-RISE) regardless of the activity code (R25 or T34), and one graduate program (either IMSD or G-RISE) regardless of the activity code (R25 or T32). Institutions with NIGMS MARC, U-RISE, IMSD, or G-RISE funding are eligible for the Bridges to the Baccalaureate and/or Bridges to the Doctorate programs provided the other eligibility criteria are met.
An institution funded through the G-RISE or IMSD program that changes category due to changes in research project grant funding during the grant cycle should apply to the appropriate program based on their eligibility at the time of renewal. Programs that change category will report on the programs outcomes of the prior funding period(s), up to 15 years, using the appropriate tables.
The sponsoring institution must assure support for the proposed program. Appropriate institutional commitment to the program should be detailed in the Institutional Support Letter in the Letters of Support attachment. Additionally, a signed letter is required from the Provost or similar official with institution-wide responsibility verifying the eligibility of the applicant institution at the time of application submission according to the eligibility criteria indicated above. See the application instructions for the required “Letters of Support” instructions in Section IV.
Modified to read (changes in italics):
Eligible Organizations
Higher Education Institutions
The following types of Higher Education Institutions are always encouraged to apply for NIH support as Public or Private Institutions of Higher Education:
Nonprofits Other Than Institutions of Higher Education
Governments
Other
For diversity enhancing programs, NIGMS recognizes separate institutional eligibility tracks: research-intensive, i.e., those with an average of NIHresearch project grant (RPG) funding greater than or equal to $7.5 million total costs per year over the past 3 fiscal years, and research-active, i.e., those with an average of RPG funding less than $7.5 million total costs per year over the past 3 fiscal years (RPG data are available through NIH RePORTER). For example, FY 2018, FY 2019 and FY 2020 for applications submitted in January 2021.
Institutional eligibility for this FOA is limited to research-active institutions as defined above. Research-intensive institutions are not eligible to apply for or receive G-RISE grants. To prevent the duplication of NIGMS diversity enhancing programs, each institution is eligible for one undergraduate program (either MARC or U-RISE) regardless of the activity code (R25 or T34), and one graduate program (either IMSD or G-RISE) regardless of the activity code (R25 or T32). Institutions with NIGMS MARC, U-RISE, IMSD, or G-RISE funding are eligible for the Bridges to the Baccalaureate and/or Bridges to the Doctorate programs provided the other eligibility criteria are met.
The application must be submitted by the eligible organization with a unique entity identifier (UEI) and a unique NIH eRA Institutional Profile File (IPF) number. For institutions with multiple campuses, eligibility can be considered for an individual campus (e.g., main, satellite, etc.) only if a UEI and a unique NIH eRA IPF number are established for the individual campus. For institutions that use one UEI or NIH IPF number for multiple campuses, eligibility is determined for the campuses together.
An institution funded through the G-RISE or IMSD program that changes category due to changes in research project grant funding during the grant cycle should apply to the appropriate program based on their eligibility at the time of renewal. Programs that change category will report on the programs outcomes of the prior funding period(s), up to 15 years, using the appropriate tables.
The sponsoring institution must assure support for the proposed program. Appropriate institutional commitment to the program should be detailed in the Institutional Support Letter in the Letters of Support attachment. Additionally, a signed letter is required from the Provost or similar official with institution-wide responsibility verifying the eligibility of the applicant institution at the time of application submission according to the eligibility criteria indicated above. See the application instructions for the required “Letters of Support” instructions in Section IV.
All other aspects of this Fundng Opportunity Announcement remain the same.
Sydella Blatch, Ph.D.
National Institute of General Medical Sciences
Email: sydella.blatch@nih.gov